Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2024)

Camp4 Therapeutics (CAMP) has disclosed Interest Expenses for 2 consecutive years, with -$145000.0 as the latest value for Q4 2024.

  • Quarterly Interest Expenses fell 274.7% to -$145000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$145000.0 through Sep 2025, down 200.0% year-over-year, with the annual reading at $192000.0 for FY2025, 481.82% up from the prior year.
  • Interest Expenses hit -$145000.0 in Q4 2024 for Camp4 Therapeutics, down from $62000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $83000.0 in Q4 2023 to a low of -$145000.0 in Q4 2024.